Live Webinar: 2018/2019 HPUS Updates

Compendial and Homeopathic Attenuation Changes

AAHP Compliance Thru Education Webinar, Wednesday, May 15, 2019

at 1:00 p.m. ET • 12:00 p.m. CT • 11:00 a.m. MT • 10:00 a.m. PT

HPCUS has continued to determine appropriate first safe attenuations for additional monographs—especially in light of FDA releasing its draft guidance. In addition, two elements of the draft guidance have added a new dimension to these evaluations and have led to labeling changes.

This webinar will review the rationale for changes in the listed first safe attenuations and present HPUS labeling wording for selected monographed substances. All manufacturers and marketers of homeopathic drug products need to be aware of these new guidelines to ensure their products and labeling do not fall into high-risk categories identified by FDA for enforcement action.

Attend this one-hour webinar to gain an overview of these changes, information on new quality-control test specifications, and changes to the HPUS Guidelines for Manufacturing Homeopathic Medicines and the HPUS Homeopathic Good Manufacturing Practices Guidelines. The webinar will also provide a glimpse of projects and activities that will be a focus of the Convention in the coming months.

Whether you manufacture or just market homeopathic drug products, the new information in the HPUS has a bearing on your products’ compliance status. Regulatory and FDA review of homeopathic products during the past year support the critical importance of being current with the updates in the HPUS. These changes and updates may affect your business, your cGMP compliance, your products and your long-term success in the market!

WHO SHOULD ATTEND

Compliance Managers

Quality Control and Quality Assurance Mangers

Staff Responsible for Product Formulations

Staff Responsible for Product and Label Review

Marketing Staff

CEO’s and Senior Management

PRESENTER

For nearly four decades, Eric Foxman R.Ph. has been involved with the HPCUS in many capacities, including on its board and as chair of the Council on Pharmacy. In this latter role, Eric has helped review and revise compendial documents to make them more current with contemporary cGMP expectations. For more than a quarter century, Eric has been also active on the Monograph Review and Standards & Controls Committees.

Many in the industry know Eric Foxman as a member or company representative of AAHP dating back to 1979. He is in the ninth year of his third term on the Board of Directors. He has worked on Continuing Education modules for pharmacists, and position statements of the association. Eric has been a presenter or host of numerous AAHP Compliance Thru Education webinars addressing legal, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. This is his seventh annual webinar on updates to the HPUS.

COST: $179. AAHP members save $90 with the discount code available from the AAHP office.

WEBINAR REGISTRATION

Registration will open shortly.

* Each Live Webinar registration is for one computer/phone connection.


* If you will be having more than one participant view the live webinar, please use the Single Participant Registration; only one name will be requested for the "registered" participant. As many people may view the webinar with that connection as you desire.


* Each registration will automatically receive one (1) Certificate of participation issued in the name of the registered participant. If you would like additional certificates of participation, a link will be provided on the confirmation page after you register to indicate how many additional certificates you wish to purchase at $39 each; you will be contacted after the event for the names to be printed on the additional certificates.

* Each separate computer/phone connection requires its own registration.

For more information regarding the seminar, contact Eric Foxman by calling 1-503-659-2715 or by emailing info@aahp.info.